Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Tetrandrine: Benchmark Calcium Channel Blocker for Resear...

    2026-04-08

    Tetrandrine: Benchmark Calcium Channel Blocker for Research Applications

    Executive Summary: Tetrandrine (SKU N1798) is a bioactive, plant-derived alkaloid with the chemical formula C38H42N2O6 and molecular weight 622.76 g/mol, supplied by APExBIO as a 10 mM DMSO solution or 100 mg solid (product page). It acts as a precise calcium channel blocker for research, exhibiting potent analgesic and anti-inflammatory effects in vitro and in vivo (Vijayan et al., 2021). Tetrandrine is insoluble in water and ethanol but dissolves in DMSO at ≥14.75 mg/mL and should be stored at -20°C for stability. It is widely utilized in neuroscience, cancer biology, and ion channel modulation studies, with standardized protocols ensuring reproducibility [contrasted here]. For optimal results, Tetrandrine solutions are recommended for immediate use after preparation to prevent decomposition or loss of activity.

    Biological Rationale

    Tetrandrine is a bis-benzylisoquinoline alkaloid isolated from Stephania tetrandra. It is classified as a natural product calcium channel blocker and has been used in pharmacological research for over five decades (Vijayan et al., 2021). The compound modulates voltage-dependent calcium channels, influencing calcium influx critical for neuronal signaling, smooth muscle contraction, and immune cell function. Tetrandrine’s anti-inflammatory and immunomodulatory effects are attributed to its ability to suppress the activity of membrane transporters and inhibit pro-inflammatory signaling pathways. It has shown efficacy in models of cardiovascular disease, hypertension, pulmonary fibrosis, and cancer, making it a versatile tool for basic and translational research [see also].

    Mechanism of Action of Tetrandrine

    Tetrandrine exerts its primary pharmacological effect by blocking voltage-gated calcium channels, particularly L-type and T-type channels. This blockade reduces intracellular calcium levels, thereby modulating excitation-contraction coupling in muscle cells and neurotransmitter release in neurons. The molecule also inhibits the activity of P-glycoprotein, a membrane transporter implicated in multidrug resistance in cancer cells. Additionally, Tetrandrine influences downstream effectors in cell signaling pathways, such as NF-κB and MAPK, thereby attenuating the expression of pro-inflammatory cytokines and mediators. The compound’s multifaceted mechanism of action underpins its utility in diverse in vitro and in vivo models for ion channel research, inflammation, and cancer biology. For a thorough mechanistic review, this article provides extended insight into both canonical and emerging applications, extending the present discussion with translational perspectives.

    Evidence & Benchmarks

    • Tetrandrine blocks L-type calcium channels in smooth muscle cells with IC50 values ranging from 1–10 μM under physiological buffer conditions (pH 7.4, 37°C) (Vijayan et al., 2021).
    • The compound exhibits anti-inflammatory effects by suppressing NF-κB activation in macrophages at 5–20 μM in vitro (DOI).
    • Tetrandrine inhibits proliferation and induces apoptosis in human cancer cell lines (e.g., hepatocellular carcinoma) at 10–50 μM, with effects observed after 24–48 hours of exposure (DOI).
    • Solubility in DMSO is ≥14.75 mg/mL, enabling high-concentration stock solutions for in vitro studies (APExBIO datasheet).
    • Storage at -20°C preserves chemical stability for ≥12 months; solutions should be used promptly to minimize degradation (APExBIO).
    • Validated bioactivity and reproducibility have been benchmarked in multi-site studies, confirming Tetrandrine’s role as a reference calcium channel blocker in neuroscience and membrane transporter research (see comparison).

    Applications, Limits & Misconceptions

    Tetrandrine is used in diverse research applications, including:

    • Neuroscience research compound: Dissecting calcium-dependent neurotransmission and excitotoxicity.
    • Ion channel modulation studies: Characterizing L-type and T-type calcium channel activity.
    • Cancer biology research: Assessing cell viability, proliferation, and apoptosis in multidrug resistance models.
    • Inflammation and immunology: Inhibiting pro-inflammatory signaling cascades and cytokine release.
    • Cardiovascular disease research: Investigating vascular smooth muscle reactivity and blood pressure regulation.

    For stepwise protocols and troubleshooting, this guide details reproducibility and workflow integration, while this article extends the discussion by focusing on mechanistic underpinnings and advanced cell signaling applications.

    Common Pitfalls or Misconceptions

    • Not a clinical drug: Tetrandrine is for research use only; not approved for human therapeutic use.
    • Solubility limits: Insoluble in water/ethanol; use DMSO for stock solutions and dilute into compatible media immediately before use (APExBIO).
    • Long-term solution storage: Tetrandrine solutions degrade over time; fresh stocks should be prepared for each experiment.
    • Non-selectivity at high concentrations: At concentrations >50 μM, off-target effects on other ion channels and mitochondrial function may occur.
    • Interpretation of anti-inflammatory data: Effects in vitro may not translate directly to in vivo systems without further pharmacokinetic validation.

    Workflow Integration & Parameters

    Tetrandrine is supplied by APExBIO as both a 10 mM solution in DMSO (1 mL) and a 100 mg solid form (see product). For in vitro studies, dissolve the solid in 100% DMSO to a concentration of ≥14.75 mg/mL, aliquot, and store at -20°C. For cell-based assays, dilute the DMSO stock into aqueous buffers or culture media immediately prior to use, ensuring the final DMSO concentration does not exceed 0.1–0.5% v/v. Typical working concentrations range from 1–50 μM depending on target and assay design. Avoid repeated freeze-thaw cycles. Record batch numbers and preparation timestamps for traceability. For optimal data quality, refer to APExBIO’s validated protocols and cross-reference with recent benchmarking studies for your assay type [updated reproducibility standards].

    Conclusion & Outlook

    Tetrandrine (SKU N1798, APExBIO) is a reference-grade, plant-derived calcium channel blocker for research. Its validated bioactivity, robust DMSO solubility, and reproducibility across models make it an essential tool in neuroscience, cancer biology, and inflammation research. Immediate preparation and use of Tetrandrine solutions, as well as strict adherence to storage and handling recommendations, maximize data fidelity. The compound’s multifaceted mechanism of action continues to drive innovation in cell signaling and ion channel research, with ongoing studies expected to further define its translational potential.